PT-141 Buyer's Guide 2026: Specs, Sourcing, and Red Flags

At a Glance: Key Sourcing Specifications

Sourcing laboratory-grade PT-141 (also known as bremelanotide) requires rigorous verification of chemical identity, purity, and freedom from bacterial contaminants. As a synthetic cyclic peptide derived from Melanotan II, PT-141 acts as a non-selective melanocortin receptor agonist, principally targeting MC3R and MC4R in central nervous system models.

To ensure experimental reproducibility across in vitro and animal models, research personnel must enforce strict quality standards before placing orders. PX1 Research sets the standard for domestic peptide supply, providing fully transparent, lot-tracked documentation with every shipment.

Below is a summary of the core criteria required when evaluating vendors for research-grade PT-141 in 2026:

• CAS Number: 189691-06-3 • Molecular Formula: C50H68N14O10 • Target Purity: ≥99.0% by HPLC peak area • Endotoxin Limit: <0.01 EU/mg verified by LAL assay • Primary Research Focus: Melanocortin receptor signaling and neuroendocrine pathway mapping • Standard Packaging: 10 mg lyophilized powder in vacuum-sealed glass vials • Dispatch & Logistics: Same-day shipping (M–F) from AZ and CA fulfillment hubs

What Is PT-141 (Bremelanotide) in Preclinical Research?

PT-141, historically designated as bremelanotide, is a synthetic peptide analogue belonging to the melanocortin class. Unlike peripheral vasoactive agents, PT-141 functions centrally by binding to central melanocortin receptors—specifically the MC3R and MC4R subtypes within the hypothalamus. Investigated for melanocortin-receptor signaling linked to sexual-health pathways, it provides researchers with a targeted chemical probe to explore neuroendocrine control over behavioral and physiological responses.

Structurally, pt141 is a cyclic heptapeptide derivative of Melanotan II (MT-2) that lacks the C-terminal amide structural element associated with strong MC1R skin-pigmentation pathways. By altering the receptor binding affinity profile, researchers can isolate central nervous system signaling pathways from cutaneous melanogenesis. Laboratories studying central autonomic modulation frequently compare PT-141 side-by-side with broader agonists like Melanotan II 10mg to map distinct receptor-subtype activation profiles.

When planning assays involving central receptor activation, selecting validated batch inventory is critical. Laboratories can inspect high-purity lots and buy PT-141 10mg vials directly from PX1 Research to guarantee structural integrity and exact sequence conformation in every experiment.

Why Lot-Specific Analytical Verification Matters for PT-141

In peptide synthesis, high-performance liquid chromatography (HPLC) and mass spectrometry (MS) are non-negotiable tools for establishing chemical identity and purity. High-purity synthesis prevents the presence of truncated peptide sequences, deletion sequences, or unreacted protecting groups that can introduce confounding biological activity into receptor binding assays.

A proper HPLC chromatogram for PT-141 must demonstrate a single sharp peak with a integrated peak area ratio reflecting ≥99.0% purity. Concurrent LC-MS analytical verification confirms the precise molecular weight (1025.2 g/mol), verifying that the cyclic peptide loop formed correctly during post-synthesis processing. Without lot-matched LC-MS reporting, laboratories risk purchasing linear precursors or improperly folded isomers that exhibit altered binding kinetics.

Furthermore, residual trifluoroacetic acid (TFA) and bacterial endotoxins present major risks to cell culture viability and animal model physiological stability. PX1 Research subjects every single batch to Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain under <0.01 EU/mg, protecting cellular assays from inflammatory artifacts. Researchers seeking full analytical confidence across their chemical inventory can explore our complete catalog of research peptides.

How to Vet a Peptide Vendor: Critical Red Flags

The market for synthetic research peptides includes numerous third-party distributors whose quality control practices fall short of institutional research standards. To prevent compromised experimental data and wasted budget, research buyers must identify red flags before issuing purchase orders.

One major red flag is the reliance on generic or 'batch representative' Certificates of Analysis (COAs). Unscrupulous vendors often publish a single COA created years prior and apply it to all subsequent inventory. Every vial received by a laboratory must correspond to a unique, lot-numbered COA accessible directly via the supplier's platform.

Additional red flags in vendor evaluation include:

• Lack of Mass Spectrometry Data: Providing only HPLC without LC-MS sequence validation, leaving molecular weight unconfirmed. • Missing Endotoxin Metrics: Failing to publish quantitative LAL assay results for injectable or cell-culture reagents. • Overseas Drop-Shipping: Routing orders through international postal systems without temperature control or verifiable customs clearance. • Regulatory Non-Compliance: Marketing compounds with human administration instructions, dosing calculators, or therapeutic claims. • Opaque Sourcing: Hiding the physical location of synthesis, analytical testing, or fulfillment operations.

Working with a supplier that maintains domestic USA fulfillment hubs and provides transparent, batch-level testing protects institutional integrity and ensures consistency across long-term trial series.

PT-141 Sourcing Evaluation Framework

To streamline vendor selection, procurement officers and principal investigators should grade prospective suppliers against a standard analytical rubric. The table below outlines the core operational and chemical standards required for high-tier peptide procurement.

Criteria | Standard Research Requirement | PX1 Research Benchmark ---|---|--- Purity Verification | ≥98.0% minimum by HPLC | ≥99.0% verified per lot by HPLC Identity Confirmation | LC-MS molecular weight match | High-resolution MS matching 1025.2 Da Endotoxin Testing | Not reported by standard vendors | LAL verified <0.01 EU/mg per batch Lot Traceability | Generic batch numbers | Unique lot number linked to downloadable COA Sourcing Origin | Undisclosed or international | USA peptide synthesis & domestic storage Dispatch Speed | 3–10 business days | Same-day dispatch (M–F before 2 PM PST) Technical Support | Automated email responses | Dedicated research-trained support team

By enforcing this rubric across all chemical purchases, research facilities reduce batch-to-batch variability and maintain strict compliance with internal quality assurance guidelines.

Is PT-141 (Bremelanotide) Legal to Purchase for Laboratory Use?

In the United States, PT-141 (bremelanotide) is legally available for purchase and possession by research institutions, academic facilities, and private laboratories as a laboratory research chemical. It is not a controlled substance under the Controlled Substances Act (CSA).

However, statutory regulations dictate that PT-141 must be strictly designated for laboratory research use only (RUO), specifically in vitro experiments and preclinical animal research. Sourcing reagents from compliant domestic vendors like PX1 Research ensures that material is synthesized, labeled, and distributed in full accordance with federal regulatory expectations, explicitly excluding human or veterinary clinical applications.

Procurement specialists should ensure that internal laboratory protocols explicitly document the analytical or preclinical scope of use when ordering research compounds.

Reconstitution and Handling Protocols for Lab Reagents

PT-141 is delivered as a freeze-dried (lyophilized) white powder in hermetically sealed glass vials to ensure long-term stability. Lyophilization preserves the peptide structure during transit, preventing enzymatic or thermal degradation.

For laboratory reconstitution, researchers typically introduce sterile bacteriostatic water (containing 0.9% benzyl alcohol) or sterile physiological saline, depending on the requirements of the downstream assay. Reconstitution should involve gently directing the diluent down the glass vial wall, followed by light swirling. Mechanical shaking must be avoided, as high shear forces can disrupt the cyclic tertiary structure.

Following reconstitution, liquid aliquots should be stored at 2°C to 8°C for short-term experimentation or frozen at -20°C to -80°C for long-term stability. To review detailed stability profiles for related neuroendocrine ligands, visit our peptide research library.

Comparing PT-141 to Other Melanocortin Receptor Agonists

Understanding where PT-141 fits within the broader family of melanocortin receptor ligands helps researchers select the appropriate probe for specific receptor subtype studies. The melanocortin system comprises five distinct G-protein coupled receptors (MC1R through MC5R), each mediating unique physiological pathways.

While early compounds like Melanotan I target MC1R to drive melanogenesis, PT-141 was specifically developed to cross the blood-brain barrier and selectively interact with central MC3R and MC4R receptors without inducing peripheral pigmentation pathways. In contrast, dual-purpose analogues like Melanotan II 10mg retain potent MC1R activity alongside central receptor binding.

By controlling receptor selectivity in experimental designs, research teams can isolate specific hypothalamic signaling pathways without confounding variables from peripheral melanocytes. Browse our full selection of melanocortin signaling peptides to compare binding affinities and molecular structures.

Bulk Procurement and Institutional Sourcing Options

High-throughput screening programs and multi-phase animal studies require substantial quantities of standardized peptide inventory. Inconsistent raw material inputs between experimental stages can invalidate statistical models and waste precious laboratory resources.

PX1 Research provides dedicated institutional procurement services, offering custom vial sizing, bulk peptide synthesis, and reserved single-lot production runs for enterprise research organizations. Working from a single consolidated synthesis batch eliminates lot-to-lot variance across multi-year research projects.

Academic department heads and laboratory procurement directors can apply for custom volume pricing and scheduled delivery frameworks through our dedicated wholesale peptide supply portal.

Ordering PT-141 from PX1 Research

When your research team is ready to order 10 mg vials of PT-141, PX1 Research provides a streamlined, fully transparent purchasing experience designed specifically for laboratory buyers.

Every unit shipped consists of high-purity lyophilized PT-141 packaged in vacuum-sealed glass vials designed to withstand long-term cold storage. Orders placed prior to 2:00 PM PST Monday through Friday are dispatched the same day from our primary fulfillment centers in Arizona and California. Domestic shipments include full tracking integration and optimized protective packaging to maintain chemical integrity throughout transit.

Every shipment is accompanied by direct access to lot-matched HPLC and mass spectrometry reports. If your laboratory requires specific purity thresholds, custom assay documentation, or bulk supply validation, our US-based technical support staff is available to assist.

To secure fully verified reagents for your lab, navigate directly to our product page to order 10 mg vials of PT-141 today.